- POSITIVE
Quarterly Revenue Global Health Sep-2026 Quarterly Revenue is Rs 1,234 Cr which is growth of 30.0% YoY.
- POSITIVE
Quarterly Net Profit Global Health Sep-2026 Quarterly Net Profit is Rs 181 Cr which is growth of 29.3% YoY.
NSE: MEDANTA | BSE: 543654
Global Health Live Share Price Today, Share Analysis and Chart
aboutGlobal Health Limited (Medanta) is a prominent private multi-specialty tertiary care provider in North and East India. Founded by cardiac surgeon Dr. Naresh Trehan, the company operates under the Medanta brand, delivering complex quaternary care ... Read More
1454.0014.30(0.99%)
135.3K
NSE+BSE Volume
NSE 13 Nov, 2026 3:31 PM (IST)
Global Health Stock Price Analysis
Day Price Range1.0% 1 Day return | 1454 (LTP) 1,4351,465 LowHigh |
|---|---|
Week Price Range4.0% 1 Week return | 1454 (LTP) 1,390.81,465 LowHigh |
Month Price Range14.0% 1 Month return | 1454 (LTP) 1,1651,465 LowHigh |
52 Week Price Range23.8% 1 Year return | 1454 (LTP) 9561,544 LowHigh |
Global Health Forecaster - Analyst Share Price Target and Estimates
Revenue forecast
EPS forecast
CURRENT EPS
AVG. ESTIMATE
Consensus Recommendation
19 ANALYST Recommendations
STRONG BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Forecaster
Competitors/Peers
Quarterly
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Global Health quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,234 | 1,102.8 | 996.4 | 964.8 | 949.2 | 905.3 | 828.5 | 646.6 | 688.2 | 638.2 | 611.2 | 587.5 | 606.4 | ||
Operating Exp. | 917.7 | 849.2 | 767.3 | 765.8 | 733.9 | 687.6 | 607.7 | 484.9 | 514.3 | 479.2 | 445.6 | 439.2 | 451.8 | |
Operating Profit | 290.4 | 229.5 | 193.3 | 174.4 | 192.6 | 194.6 | 195.2 | 139.5 | 150.3 | 132.3 | 122.2 | 122.5 | 128.3 | |
Operating Profit Margin % | 24.04% | 21.28% | 20.13% | 18.55% | 20.79% | 22.06% | 24.31% | 22.35% | 22.62% | 21.64% | 21.12% | 21.81% | 22.12% | |
Depr. | 56.2 | 54.6 | 52.2 | 47.9 | 37.4 | 33.4 | 38 | 23.4 | 24.9 | 23.3 | 23.4 | 21.7 | 21.5 | |
Interest | 17.1 | 15.9 | 13.5 | 13.1 | 8.9 | 5.7 | 7.1 | 5.9 | 5.4 | 6 | 6.2 | 5.8 | 6.1 | |
Profit Before Tax | 243.1 | 183.1 | 163.5 | 102.9 | 185.1 | 198.3 | 125.9 | 132.3 | 143.6 | 129.7 | 125.2 | 120.9 | 126.9 | |
Tax | 61.8 | 45.8 | 39.3 | 23 | 44.9 | 46.3 | 32.5 | 33 | 39.1 | 33.5 | 32.9 | 33.5 | 31.8 | |
Net Profit | 181.3 | 137.3 | 124.1 | 79.9 | 140.2 | 152 | 93.4 | 99.3 | 104.5 | 96.3 | 92.2 | 87.3 | 95.1 | |
EPS Adj. latest | 6.7 | 5.1 | 4.6 | 3 | 5.2 | 5.7 | 3.5 | 3.7 | 3.9 | 3.6 | 3.4 | 3.3 | 3.5 | |
Net profit TTM | 522.6 | 481.5 | 496.2 | 465.5 | 484.9 | 449.2 | 393.5 | 392.3 | 380.3 | 371 | 360.9 | 349.6 | 321 | |
Basic EPS TTM | 19.5 | 17.9 | 18.5 | 17.3 | 18 | 16.7 | 14.7 | 14.6 | 14.2 | 13.8 | 13.4 | 13 | 12 | |
Earnings Transcripts | ||||||||||||||
AI Summary | ||||||||||||||
Results PDF | ||||||||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Global Health Technical Analysis
Global Health EMA & SMA
Bullish+8
8 bullish, 0 bearish
Bullish8
Bearish0
| 5 Day | 1428.7 |
|---|---|
| 10 Day | 1396.3 |
| 12 Day | 1386.0 |
| 20 Day | 1362.6 |
| 26 Day | 1356.9 |
|---|---|
| 50 Day | 1357.0 |
| 100 Day | 1343.1 |
| 200 Day | 1303.0 |
Global Health Delivery And Volume
Daily Avg. Delivery Volume %
13 Nov, 202658.4%
Week58.8%
Month57.5%
Global Health Active Candlesticks
Short Line Uptrend Spinning Top Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Global Health Resistance and Support
1451.33
Pivot
| First Resistance | 1467.7 |
|---|---|
| Second Resistance | 1481.3 |
| Third Resistance | 1497.7 |
| First Support | 1437.7 |
|---|---|
| Second Support | 1421.3 |
| Third Support | 1407.7 |
| Day RSI | 68 |
|---|---|
| Day MACD | 29.1 |
| Day MFI | 95.9 |
| Day MACD Signal Line | 7.3 |
Global Health Beta
| 1 Month | 0.2 |
|---|---|
| 1 Year | 0.7 |
| 3 Month | 0.3 |
|---|---|
| 3 Year | 0.6 |
Global Health Price Change Analysis
↑14.0%
Over 1 Month
LowHigh
11651465
↑2.2%
Over 3 Months
LowHigh
11651544
↑17.0%
Over 6 Months
LowHigh
11531544
↑23.8%
Over 1 Year
LowHigh
9561544
Global Health Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| SUNIL SACHDEVA | Block | Sell | 25 Jun 2026 | 1300 | 1,000,000 | BSE |
| HDFC MUTUAL FUND | Block | Purchase | 25 Jun 2026 | 1300 | 1,000,000 | BSE |
| SUNIL SACHDEVA | Block | Sell | 25 May 2026 | 1225 | 1,000,000 | NSE |
| HDFC MUTUAL FUND | Block | Purchase | 25 May 2026 | 1225 | 1,000,000 | NSE |
| JM FINANCIAL INSTITUTIONAL SECURITIES LIMITED | Bulk | Purchase | 14 Feb 2024 | 1315.22 | 3,000,000 | BSE |
| DUNEARN INVESTMENTS MAURITIUS PTE LIMITED | Bulk | Sell | 14 Feb 2024 | 1315.20 | 3,000,000 | BSE |
| JM FINANCIAL INSTITUTIONAL SECURITIES LIMITED | Bulk | Sell | 14 Feb 2024 | 1315.05 | 3,000,000 | BSE |
| RJ CORP LIMITED | Bulk | Purchase | 14 Feb 2024 | 1315 | 2,882,203 | BSE |
| JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED | Block | Sell | 18 Jan 2024 | 1030.05 | 297,792 | BSE |
| THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT | Block | Purchase | 18 Jan 2024 | 1030.05 | 297,792 | BSE |
Global Health Corporate Actions
Global Health Dividend history and yield
Global Health dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Global Health dividend yield over time.
#Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
114 Aug 2026 | 0.5 | FINAL | 14 Aug 2026 | Equity Share |
222 Aug 2025 | 0.5 | FINAL | 22 Aug 2025 | Equity Share |
Global Health Board Meetings
Global Health past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
103 Nov 2026 | Quarterly Results | - |
230 Jul 2026 | Quarterly Results | - |
314 May 2026 | Audited Results & Final Dividend | - |
404 Feb 2026 | Quarterly Results | - |
507 Nov 2025 | Quarterly Results | - |
Global Health Research Reports
Global Health research reports with share price targets, and buy/hold/sell recommendations from top brokers.
# Date | Broker Name | Target | Price When Recommended | Type | Upside | Change Since Recommendation | Links |
|---|---|---|---|---|---|---|---|
| 110 Nov 2026 | Anand Rathi Target | 1710 | 1429 | Buy | 19.66% | 1.75% | |
| 204 Nov 2026 | Axis Direct Target | 1615 | 1389.7 | Buy | 16.21% | 4.63% | |
| 324 Aug 2026 | Prabhudas Lilladhar Target | 1750 | 1404.4 | Buy | 24.61% | 3.53% | |
| 431 Jul 2026 | Motilal Oswal Target | 1670 | 1405.6 | Buy | 18.81% | 3.44% | |
| 518 May 2026 | Anand Rathi | 1400 | 1240.4 | Buy | 12.87% | 17.22% |
Global Health Corporate Filings
Global Health BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 14 Nov 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation | Investor Presentation for the Analyst/Investors Meet . | |
| 10 Nov 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. | |
| 10 Nov 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. | |
| 10 Nov 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. | |
| 10 Nov 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. |
Global Health Documents
Global Health Earnings Call
Global Health earnings calls, including management commentary and AI-generated summaries.
| Date | Title | Links |
|---|---|---|
| 10 Nov 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | |
| 04 Nov 2026 | Global Health Results Earnings Call for Q2FY27 | AudioVideo |
| 05 Aug 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | |
| 31 Jul 2026 | Global Health Results Earnings Call for Q1FY27 | AudioVideo |
| 20 May 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Global Health Annual Reports
Global Health financials, including annual results, balance sheets, and cash flow statements.
Global Health Credit Ratings
Global Health credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.
| Date | Rating Agency | Company Name | Description | Links |
|---|---|---|---|---|
| 15 Dec 2025 | crisil ratings | Global Health Limited | Global Health Limited:Long-term rating upgraded to 'Crisil AA/Stable'; Short-term rating reaffirmed | Link |
| 09 Dec 2025 | crisil ratings | Global Health Research and Management Institute | Global Health Research and Management Institute:Issuer not cooperating, based on best-available information; Rating continues to be \u2018Crisil D Issuer not cooperating\u2019 | Link |
| 15 Oct 2025 | crisil ratings | Global Health Limited | Global Health Limited:Update on Global Health Limited | Link |
| 14 Jul 2025 | brickwork ratings | Global Health Research and Management Institute | Issuer did not cooperate; Based on best available information; Continues to be in ISSUER NOT COOPERATING* category/Reaffirmed; | |
| 16 Mar 2025 | crisil ratings | Global Health Limited | Global Health Limited:Rated amount enhanced for Bank Debt | Link |
Global Health Investor Presentations
Global Health investor presentations, including business updates, financial insights, and strategic initiatives.
| Date | Report Title | Links |
|---|---|---|
| 14 Nov 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation | |
| 03 Nov 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation | |
| 30 Jul 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation | |
| 14 May 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation | |
| 04 Feb 2026 | Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation |
Global Health - Company Profile
Global Health Management Structure
Global Health management structure with salaries, total experience, and qualifications.
Global Health Board of Directors
Global Health Board of directors with salaries, total experience, and qualifications.
Website: www.medanta.org
About the company - Business Profile
Global Health Limited (Medanta) is a prominent private multi-specialty tertiary care provider in North and East India. Founded by cardiac surgeon Dr. Naresh Trehan, the company operates under the Medanta brand, delivering complex quaternary care across a network of super-specialty hospitals. It maintains a leadership position in several high-demand specialties including cardiac sciences, neurosciences, oncology, and liver transplants.
Key Points
- Key Facts:
- Founded: 2004 (Flagship hospital opened in 2009).
- Headquarters: New Delhi, India.
- Stock Listing: Listed on BSE and NSE on November 16, 2022.
- Core Offerings: Multi-specialty healthcare services across 30+ medical specialties.
- Operations and Resources:
- Network: Operates 6 hospitals in Gurugram, Indore, Ranchi, Lucknow, Patna, and a newly operational unit in Noida (commenced 2025).
- Capacity: As of December 31, 2025, the company had 3,550+ installed beds.
- Flagship Asset: Medanta - The Medicity (Gurugram) is the largest single-location private hospital in the National Capital Region (NCR), with 1,440 installed beds and 40 operation theatres.
- Expansion: Developing new facilities in Pitampura (750 beds), South Delhi (400 beds), and Guwahati (400 beds).
- Market Significance and Business Model:
- Business Model: Medanta follows a doctor-led model focusing on high-end tertiary and quaternary care (complex medical procedures).
- Patient Reach: Serves a population base of over 400 million people across North and East India and treats international patients from 130+ countries.
- Financial Performance (FY 2024-25):
- Total Income: Rs. 37,714 million (reflecting a 26% CAGR from FY 2021).
- EBITDA: Rs. 9,562 million with an EBITDA margin of 25.4%.
- Profit After Tax (PAT): Rs. 4,813 million (102% CAGR since FY 2021).
- ARPOB (Average Revenue Per Occupied Bed): Rs. 62,722 per day in FY 2025.
- Revenue Breakdown: Primarily derived from hospital and medical care services (90%+ of turnover).
- Technology and Innovation:
- Medical Equipment: Utilization of Da Vinci Xi Single robotic system and Magnetom Vida MRI System.
- Specialized Units: Recently launched a dedicated floor for mother and child at the Gurugram facility with 49 beds.
- Human Resources:
- Workforce: Engages over 1,800+ doctors and a total staff of approximately 10,500+ employees (including 6,250+ nurses and paramedics).
- Incentives: Implemented the Global Health Limited Employees Long-Term Share-Based Incentive Plan-2024.
- Current Strategic Initiatives:
- Bed Capacity Growth: Targeted to reach a total capacity of over 5,000 beds through ongoing expansions in Noida, Delhi, and Guwahati.
- Integration: Focused on digital health initiatives and expanding Medanta Labs (10 labs and 120 collection centers) and pharmacies.
References
